NEMIC Advisor Appointed as Fractional CEO to April 2018 Cohort Participant, Aurios Medical

We are excited to announce the appointment of David Robson, NEMIC Advisor, as the fractional CEO for the US-based division of Aurios Medical.  Aurios Medical, based in South Korea, was a part of the April 2018 cohort participating in our Med Tech Global Accelerator Program.

Aurios Medical creates high fidelity intravascular imaging/sensing platforms to predict high risk plaque and optimize percutaneous coronary intervention procedures.  With the goal of identifying high risk plaque with high confidence and optimizing percutaneous coronary intervention therapy. 


Congrats David!